RT Journal Article
SR Electronic
T1 Development of a Core Domain Set of Outcomes for Shared Decision Making Interventions: An Omeract White Paper and Stakeholder Interviews
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.181071
DO 10.3899/jrheum.181071
A1 Karine Toupin  April
A1 Jennifer L.  Barton
A1 Liana Fraenkel
A1 Alexa Meara
A1 Linda C.  Li
A1 Peter Brooks
A1 Maarten de Wit
A1 Dawn Stacey
A1 France Légaré
A1 Beverley Shea
A1 Anne Lyddiatt
A1 Cathie Hofstetter
A1 Robin Christensen
A1 Marieke Scholte  Voshaar
A1 Maria E.  Suarez-Almazor
A1 Annelies Boonen
A1 Tanya Meade
A1 Lyn March
A1 Janet Elizabeth  Jull
A1 Willemina Campbell
A1 Rieke Alten
A1 Suvi Karuranga
A1 Esi M.  Morgan
A1 Ayano Kelly
A1 Jessica Kaufman
A1 Sophie Hill
A1 Lara J.  Maxwell
A1 Dorcas Beaton
A1 Yasser El-Miedany
A1 Shikha Mittoo
A1 Susan J.  Bartlett
A1 Jasvinder A.  Singh
A1 Peter Tugwell
YR 2019
UL http://www.jrheum.org/content/early/2019/01/23/jrheum.181071.abstract
AB Objective The Outcome Measures in Rheumatology (OMERACT) shared decision making (SDM) Working Group aims to determine the core outcome domain set for measuring the effectiveness of SDM interventions in rheumatology trials. Methods A white paper was developed to clarify the draft core domain set. It was then used to prepare stakeholders for interviews to explore reasons for lack of consensus on it and to suggest further improvements. Results OMERACT scientists/clinicians (n=13) and patients (n=10) suggested limiting the core domain set to outcome domains, removing process domains, and clarifying remaining domains. Conclusion A revised core domain set will undergo further consensus-building.